Drugs News and Research

RSS

Green tea compound has high potential as treatment for rheumatoid arthritis

Researchers at Washington State University in Spokane have identified a potential new approach to combating the joint pain, inflammation and tissue damage caused by rheumatoid arthritis.

17 Feb 2016

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

The Walter Reed Army Institute of Research began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).

17 Feb 2016

Special issue of FMCH focuses on care and disease management interventions in China, Australia

A Sino-Australian forum is the theme of the new issue of Family Medicine and Community Health (FMCH), an international medical journal with editorial offices in China and the U.S.

17 Feb 2016

Misuse of Adderall drug rising among young adults, research suggests

While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new Johns Hopkins Bloomberg School of Public Health research suggests.

17 Feb 2016

Experts available to discuss use of meningitis vaccine in childhood immunization programs

Global vaccine experts and officials from all 26 African "meningitis belt" countries will convene in Ethiopia next week in advance of the Ministerial Conference on Immunization to celebrate one of Africa's biggest public health achievements--the introduction of a vaccine that in five years of use has protected more than 235 million people in 16 countries, nearly eliminating meningitis A disease on the continent.

17 Feb 2016

New vaccine strategy may curb addiction, prevent fatal overdoses

With use of synthetic opioid "designer drugs" on the rise, scientists from The Scripps Research Institute have a new strategy to curb addiction and even prevent fatal overdoses.

17 Feb 2016

Beige-fat formation could be harnessed to fight diabetes

Researchers are getting closer to learning how to turn white fat cells into brown fat cells, in a process called "beiging," to bring down blood sugar levels and fight diabetes.

17 Feb 2016

New UNC School of Medicine study shows how some bacteria can spread throughout the body

Bacteria have evolved thousands of clever tactics for invading our bodies while evading our natural defenses. Now, UNC School of Medicine scientists studying one of the world's most virulent pathogens and a separate very common bacterium have discovered a new way that some bacteria can spread rapidly throughout the body - by hitchhiking on our own immune cells.

16 Feb 2016

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

For rent: 32 individual rooms for a combined surface area of 4cm2, heating and food included! Biologists and microfluidics specialists at EPFL have joined forces and developed a highly innovative research tool: a 2cm by 2cm 'chip' with 32 independent compartments, each of which is designed to hold a nematode - a widely used worm in the research world. The device is described in the journal Molecular Neurodegeneration.

16 Feb 2016

Survey: 43% of Americans likely to pay more for health insurance in 2016

According to the latest survey conducted by leading personal finance website GOBankingRates.com, 43 percent of Americans expect to pay more for health insurance in 2016, with 23 percent expecting to pay "a little more than the last year" and 20 percent expecting to pay "a lot more than the last year."

16 Feb 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

16 Feb 2016

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that VIVLODEX (meloxicam) capsules, a nonsteroidal anti-inflammatory drug (NSAID), is now available by prescription at pharmacies across the United States.

16 Feb 2016

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Celator Pharmaceuticals, Inc. today announced that the Phase 3 clinical trial of VYXEOS (cytarabine:daunorubicin) Liposome for Injection (also known as CPX-351) in patients with untreated high-risk (secondary) acute myeloid leukemia (AML) has reached its pre-specified number of events required for the analysis of overall survival.

16 Feb 2016

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

Researchers at the University of Michigan Life Sciences Institute and School of Public Health have discovered a new class of anti-biofilm compounds derived from marine microorganisms that show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.

16 Feb 2016

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

Nine weekly sessions of individually tailored acupuncture lessen perceived pain intensity, and improve functional capacity and quality of life, in people with the chronic pain condition, fibromyalgia, finds research published online in Acupuncture in Medicine.

16 Feb 2016

Study could pave way for new treatment strategies for PKU

Phenylketonuria, also known as PKU, is the most common inherited disease affecting amino acid metabolism. Children are tested for PKU at birth, and babies diagnosed with the disease must adhere to a highly restricted diet to prevent permanent intellectual impairment.

16 Feb 2016

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

16 Feb 2016

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Delirium, muscle weakness and other neurological complications of sepsis often are overlooked and poorly understood, according to a study published in the journal Current Neurology and Neurosciences Reports.

16 Feb 2016

New study to evaluate use of whole umbilical cord blood to accelerate stroke recovery

A new study will evaluate the use of whole umbilical cord blood to help the brain heal quicker after an ischemic stroke.

16 Feb 2016

Research findings identify potential genetics-guided precision medicine for leukemia patients

An international research team has determined how inherited gene variations lead to severe drug toxicity that may threaten chances for a cure in children with leukemia. St. Jude Children's Research Hospital scientists led the study, results of which set the stage to expand the use of a patient's genetic make-up to tailor chemotherapy.

16 Feb 2016

Drugs News and Research

Green tea compound has high potential as treatment for rheumatoid arthritis

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

Special issue of FMCH focuses on care and disease management interventions in China, Australia

Misuse of Adderall drug rising among young adults, research suggests

Experts available to discuss use of meningitis vaccine in childhood immunization programs

New vaccine strategy may curb addiction, prevent fatal overdoses

Beige-fat formation could be harnessed to fight diabetes

New UNC School of Medicine study shows how some bacteria can spread throughout the body

Innovative tool helps observe protein aggregates linked to neurodegenerative diseases

Survey: 43% of Americans likely to pay more for health insurance in 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Celator provides update on Phase 3 clinical trial of VYXEOS in patients with untreated high-risk AML

Anti-biofilm compounds show promise against drug-resistant bacteria associated with hospital-acquired infections

Tailored acupuncture reduces pain intensity, improves quality of life in people with fibromyalgia

Study could pave way for new treatment strategies for PKU

UAB research reveals heterogonous population of leukemia stem cells

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

New study to evaluate use of whole umbilical cord blood to accelerate stroke recovery

Research findings identify potential genetics-guided precision medicine for leukemia patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News